Lung cancer showdown: surgery or radiation – which is better?

NCT ID NCT05183932

Ongoing Knowledge-focused Sponsor: Washington University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jan 09, 2026 · Last updated Jun 14, 2026 · Updated 22 times

Summary

This study compares two common treatments for stage I non-small cell lung cancer: surgery and stereotactic body radiation therapy (SBRT). About 446 patients will report their quality of life and symptoms for up to 3 years after treatment. The goal is to see which approach offers better survival and daily well-being.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Carle Cancer Institute

Urbana, Illinois, 61801, United States
Cleveland Clinic

Cleveland, Ohio, 44195, United States
Duke University

Durham, North Carolina, 27710, United States
Emory University

Atlanta, Georgia, 30322, United States
Memorial Sloan Kettering

New York, New York, 10065, United States
University of Texas MD Anderson Cancer Center

Houston, Texas, 77030, United States
University of Toronto

Toronto, Ontario, Canada
Washington University School of Medicine

St Louis, Missouri, 63110, United States

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON SMALL CELL LUNG CANCER NON SMALL CELL LUNG CANCER